.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Daiichi Sankyo
Moodys
Boehringer Ingelheim
Argus Health
UBS
Teva
Chubb
Healthtrust
Citi

Generated: September 24, 2017

DrugPatentWatch Database Preview

Claims for Patent: ► Subscribe

« Back to Dashboard

Claims for Patent: ► Subscribe

Title: Cleansing compositions
Abstract:The disclosure relates to cleansing compositions containing a soluble salt of chlorhexidine, a polyoxyethylene-polyoxypropylene block co-polymer and an inert diluent or carrier.
Inventor(s): Billany; Michael Royston (Macclesfield, EN), Longworth; Arthur Raymond (Macclesfield, EN), Shatwell; John (Macclesfield, EN)
Assignee: Imperial Chemical Industries Limited (London, EN)
Application Number:05/512,483
Patent Claims: 1. A skin cleansing composition consisting essentially of from 0.5 to 10.0% w/v of a salt of chlorhexidine which is soluble to the extent of at least 0.5% w/v in water at ambient temperature, selected from the group consisting of the gluconate, isethionate, formate, acetate, glutamate, succinamate, mono-diglycollate, dimethanesulphonate, lactate, diisobutyrate and glucoheptonate salts, between 10 and 30% of a polyoxyethylene-polyoxypropylene block copolymer of the formula: ##EQU2## wherein a, b and c are integers, such that said copolymer consists of 40 to 70% of polyoxyethylene and wherein the molecular weight of the polyoxypropylene content is between 2000 and 2500, and water.

2. The composition of claim 1 which contains from 0.5 to 5.0% of chlorhexidine gluconate.

3. The composition of claim 1 which additionally contains an amine oxide foaming agent selected from the group consisting of cetyldimethylamine oxide, lauryldimethylamine oxide, cetylmethylmyristylamine oxide and dimethylmyristylamine oxide.

4. A composition according to claim 1 wherein gluconolactone is included to provide a pH between 5 and 7.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Chinese Patent Office
QuintilesIMS
Deloitte
Argus Health
Express Scripts
Queensland Health
US Army
Federal Trade Commission
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot